Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Douglas

Showing results (691-700 of 716) with videos related to

Pageof 72
Sort By:
Lancet (London, England)|July 24, 2020
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialPedro M Folegatti, Katie J Ewer, Parvinder K Aley, et al.
Biotechnology and Bioengineering|September 29, 2021
Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needsCarina C D Joe, Jinlin Jiang, Thomas Linke, et al.
The Journal of Infectious Diseases|October 23, 2014
Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individualsSusanne H Hodgson, Katie J Ewer, Carly M Bliss, et al.
Plos One|July 30, 2011
Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909Christopher J A Duncan, Susanne H Sheehy, Katie J Ewer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 24, 2012
ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humansSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
NPJ Vaccines|August 23, 2018
Production, quality control, stability, and potency of cGMP-produced <i>Plasmodium falciparum</i> RH5.1 protein vaccine expressed in <i>Drosophila</i> S2 cellsJing Jin, Richard D Tarrant, Emma J Bolam, et al.
Cell|June 18, 2019
Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing AntibodiesDaniel G W Alanine, Doris Quinkert, Rasika Kumarasingha, et al.
Nature Communications|June 7, 2024
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complexBarnabas G Williams, Lloyd D W King, David Pulido, et al.
The Journal of Trauma and Acute Care Surgery|May 28, 2025
Damage control thoracotomy trends, techniques, and outcomes: An EAST multicenter trialAnthony D Douglas, Teddy Puzio, Partick Murphy, et al.
Nature Medicine|December 18, 2020
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trialKatie J Ewer, Jordan R Barrett, Sandra Belij-Rammerstorfer, et al.
Pageof 72

Showing results (691-700 of 716) with videos related to

Sort By:
Pageof 72
Lancet (London, England)|July 24, 2020
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialPedro M Folegatti, Katie J Ewer, Parvinder K Aley, et al.
Biotechnology and Bioengineering|September 29, 2021
Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needsCarina C D Joe, Jinlin Jiang, Thomas Linke, et al.
The Journal of Infectious Diseases|October 23, 2014
Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individualsSusanne H Hodgson, Katie J Ewer, Carly M Bliss, et al.
Plos One|July 30, 2011
Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909Christopher J A Duncan, Susanne H Sheehy, Katie J Ewer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 24, 2012
ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humansSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
NPJ Vaccines|August 23, 2018
Production, quality control, stability, and potency of cGMP-produced <i>Plasmodium falciparum</i> RH5.1 protein vaccine expressed in <i>Drosophila</i> S2 cellsJing Jin, Richard D Tarrant, Emma J Bolam, et al.
Cell|June 18, 2019
Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing AntibodiesDaniel G W Alanine, Doris Quinkert, Rasika Kumarasingha, et al.
Nature Communications|June 7, 2024
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complexBarnabas G Williams, Lloyd D W King, David Pulido, et al.
The Journal of Trauma and Acute Care Surgery|May 28, 2025
Damage control thoracotomy trends, techniques, and outcomes: An EAST multicenter trialAnthony D Douglas, Teddy Puzio, Partick Murphy, et al.
Nature Medicine|December 18, 2020
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trialKatie J Ewer, Jordan R Barrett, Sandra Belij-Rammerstorfer, et al.
Pageof 72